Skip Navigation
ChemIDplus A TOXNET DATABASE LiteBrowseAdvanced

Substance Name: Yttrium Y 90 Labetuzumab Tetraxetan [USAN]
RN: 501423-30-9
UNII: QTV68S4T5M

Classification Code

  • Radioimmunotherapy (RAIT) for CEA-Expressing Tumors in Colorectal,Pancreatic, Lung, Breast, Ovarian, and Medullary Thyroid Cancer

Molecular Formula

  • Unspecified

Molecular Weight

  • 489.4015
 
* denotes mobile formatted website

Links to Resources

NLM Resources (File Locators)

Other Resources (Internet Locators)

Names and Synonyms

Name of Substance

  • Yttrium Y 90 Labetuzumab Tetraxetan [USAN]

Synonyms

  • (sup 90)Y-DOTA-hMN14
  • 90Y-DOTA-hMN14
  • UNII-QTV68S4T5M
  • Yttrium Y 90 Labetuzumab Tetraxetan

Systematic Names

  • Immunoglobulin G1 (human-mouse monoclonal hMN-14 gamma-chain anti-human carcinoembryonic antigen), disulfide with human-mouse monoclonal hMN-14 kappa-chain, dimer, 2,2,2,2-(1,4,7,10-tetraazacyclododecane-1,4,7,10-tetryl)tetraacetic acid conjugate, yttrium-90Y chelate. Molecular weight is approximately 150,000 daltons
  • Immunoglobulin G1, anti-(human carcinoembryonic antigen) (human-mouse monoclonal hMN-14 gamma-chain), disulfide with human-mouse monoclonal hMN-14 kappa-chain, dimer, 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid conjugate, yttrium-90Y chelate

Registry Numbers

CAS Registry Number

  • 501423-30-9

FDA UNII

  • QTV68S4T5M

System Generated Number

  • 0501423309